Seizure Decision Tool

Seizure Decision Tool

Atif Elnil

Available on Google Play
50+ installsFreeEducation

Updated Jul 29, 2026 ยท v1.2

CompareView on Google Play โ†—
Screenshot 1
Screenshot 2
Screenshot 3
Screenshot 4
Screenshot 5
Screenshot 6
Screenshot 7
Screenshot 8
Screenshot 9
Screenshot 10
Screenshot 11
Screenshot 12

Bedside decisions for new-onset seizures, seizure emergencies, scans & driving

Seizure Decision Tool is a fast, evidence-based decision-support reference for clinicians managing patients with seizures โ€” in the emergency department, on the acute medical take, on-call, in neurology, and in general practice. When someone has a seizure, the decisions come quickly: is this provoked or unprovoked? Do they need a scan today? Should an anti-epileptic drug be started? Is this status epilepticus โ€” and if so, what goes in, and when? This tool walks you through each of those decisions clearly, so you can act with confidence at the bedside. WHAT'S INSIDE - First Seizure โ€” Initial Assessment Provoked vs unprovoked classification, bloods, when to image, EEG, and the neurology referral timelines. - Provoked vs Unprovoked Seizure Acute symptomatic causes to identify and treat, recurrence risk, and the evidence-based AED decision after a first seizure. - Status Epilepticus โ€” Time-Critical Protocol A minute-by-minute pathway from stabilisation through first-line benzodiazepines, second-line agents, and refractory management โ€” built around treating at 5 minutes, not 30. - When to Scan โ€” CT, MRI and EEG Same-day CT indications, the elective epilepsy-protocol MRI, and what an EEG does and does not tell you. - First Fit โ€” Elderly vs Young Adult Different causes, different risks, different thresholds across age groups. - PRES โ€” Posterior Reversible Encephalopathy Syndrome Recognition, the MRI pattern, and management. - DVLA Driving Rules Group 1 and Group 2 licence restrictions for first seizures, established epilepsy, nocturnal seizures, and medication changes โ€” with a documentation checklist. - References & Citations Every recommendation is linked to its source โ€” NICE NG217 (2022), SIGN 70, DVLA (2022), MHRA, and landmark trials including ESETT, ConSEPT, Magpie, and the ILAE definitions. DESIGNED FOR THE WAY YOU WORK - Works fully offline โ€” no connection needed at the bedside. - Clean, fast, distraction-free interface. - Adjustable text size. - No accounts, no tracking, no ads. FREE TO TRY The First Seizure assessment and the Provoked vs Unprovoked pathway are free to explore. A single one-time in-app purchase (ยฃ9.99) unlocks the full tool โ€” Status Epilepticus, When to Scan, Elderly, PRES, DVLA guidance, and the complete References library. One-time purchase, no subscription. IMPORTANT โ€” FOR HEALTHCARE PROFESSIONALS This app is an educational and training decision-support tool intended for qualified healthcare professionals. It does not replace current national or local guidelines, formularies, or your own clinical judgement. Always confirm doses against the BNF and your local protocols, and seek senior review for complex cases. It is not intended for use by patients to self-diagnose or self-manage. Developed by Dr Atif Elnil (MBBS, MRCP), Neurology and Stroke Fellow.

Released
June 25, 2026

0 years on Google Play

Version
1.2
Updated
Jul 29, 2026
Content Rating
Everyone
Installs
50+
Developer
Atif Elnil
Website
https://atif-elnil-android-privacy.netlify.app/
Email
Atif.elnil@gmail.com
In-app purchases
No

This app isn't currently appearing in any tracked top charts.

Rating breakdown

5โ˜…
0
4โ˜…
0
3โ˜…
0
2โ˜…
0
1โ˜…
0